Holding(s) in Company

Summary by AI BETAClose X

Jonathan Mark Swann has increased his holding in Genflow Biosciences PLC, crossing a notification threshold on January 23, 2026. His total voting rights now stand at 12.13%, representing 59,861,278 shares, up from a previous notification of 11.32%. This acquisition of voting rights is the sole reason for the notification, with no financial instruments involved.

Disclaimer*

UK 100

Latest directors dealings